| Novartis Pharma Schweiz AG - Tafinlar 75 mg, Hartkapseln | | 62781 | | 02 | | Tafinlar 75 mg | | Hartkapseln | | L01EC02 | | Dabrafenib | | 13.01.2014 | | |
| | Composition | | dabrafenibum 75.0 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Dabrafenibum | 75 mg |
| | BAG: Active Agent | Dose |
|---|
| Dabrafenibum | 75 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Ammonii Hydroxidum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Kapselhülle | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
